SCAI Expert Opinion Highlights Advances in Wire-Free Angiography-Derived Physiology for Coronary Assessment

Why It Matters

ADP could dramatically increase the use of physiology‑guided interventions, cutting costs and improving patient comfort while preserving diagnostic accuracy. Its adoption reshapes interventional cardiology workflows and market dynamics.

Key Takeaways

• ADP provides wire‑free physiological assessment from angiograms
• Reduces procedural time, cost, and patient discomfort
• Adoption limited by image quality and operator expertise
• AI-driven models improve accuracy, yet need outcome validation
• Training programs essential for safe, effective ADP use

Pulse Analysis

Angiography‑derived physiology represents a convergence of imaging and artificial intelligence that is redefining how cardiologists evaluate coronary artery disease. By extracting pressure gradients and flow reserve values directly from routine angiographic runs, ADP eliminates the need for invasive pressure wires, which have traditionally been limited to a minority of cases due to procedural complexity and patient tolerance. The technology leverages computational fluid dynamics and machine‑learning algorithms to model blood flow, delivering real‑time functional insights that complement the anatomical detail of conventional angiography.

Clinical integration of ADP is gaining traction, especially in catheterization labs seeking to streamline workflows and reduce procedural costs. The SCAI expert roundtable highlighted scenarios where ADP excels, such as multivessel disease assessment, planning percutaneous coronary interventions, and evaluating non‑culprit lesions in acute coronary syndromes. However, the accuracy of these models hinges on high‑quality image acquisition—multiple projections, minimal artifacts, and consistent contrast timing are essential. Consequently, structured training programs are emerging to equip interventionalists with the technical and interpretive skills required for reliable ADP use, addressing the current gap between technology availability and operator proficiency.

Looking ahead, continuous refinement of AI algorithms and broader real‑world validation studies are poised to cement ADP’s role in personalized cardiovascular care. Partnerships with device manufacturers are accelerating platform usability, while ongoing research aims to demonstrate tangible outcome improvements, such as reduced repeat revascularizations and shorter hospital stays. As evidence accumulates, payers and health systems are likely to recognize ADP’s cost‑effectiveness, potentially reshaping reimbursement models and driving wider adoption across both academic and community settings. The evolution of ADP thus signals a paradigm shift toward less invasive, data‑rich decision‑making in interventional cardiology.